Which has better valuation & earnings, AORT or LIVN?

Artivion has higher earnings, but lower revenue than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Artivion $441.33M 2.83 $9.77M $0.24 107.29 LivaNova $1.39B 3.24 -$242.47M $1.95 41.94

Is AORT or LIVN more profitable?

LivaNova has a net margin of 7.48% compared to Artivion's net margin of 2.55%. LivaNova's return on equity of 16.48% beat Artivion's return on equity. Company Net Margins Return on Equity Return on Assets Artivion 2.55% 7.15% 3.63% LivaNova 7.48% 16.48% 7.59%

Does the media favor AORT or LIVN?

In the previous week, LivaNova had 2 more articles in the media than Artivion. MarketBeat recorded 3 mentions for LivaNova and 1 mentions for Artivion. LivaNova's average media sentiment score of 1.68 beat Artivion's score of 0.00 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artivion 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LivaNova 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor AORT or MMED?

In the previous week, MiniMed Group had 6 more articles in the media than Artivion. MarketBeat recorded 7 mentions for MiniMed Group and 1 mentions for Artivion. MiniMed Group's average media sentiment score of 0.51 beat Artivion's score of 0.00 indicating that MiniMed Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artivion 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, AORT or NVST?

Envista has higher revenue and earnings than Artivion. Envista is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Artivion $441.33M 2.83 $9.77M $0.24 107.29 Envista $2.72B 1.61 $47M $0.41 65.82

Is AORT or NVST more profitable?

Artivion has a net margin of 2.55% compared to Envista's net margin of 2.41%. Artivion's return on equity of 7.15% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets Artivion 2.55% 7.15% 3.63% Envista 2.41% 7.11% 3.91%

Does the media favor AORT or NVST?

In the previous week, Envista had 3 more articles in the media than Artivion. MarketBeat recorded 4 mentions for Envista and 1 mentions for Artivion. Envista's average media sentiment score of 0.72 beat Artivion's score of 0.00 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artivion 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envista 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to IRTC or AORT?

In the previous week, iRhythm Technologies had 4 more articles in the media than Artivion. MarketBeat recorded 5 mentions for iRhythm Technologies and 1 mentions for Artivion. iRhythm Technologies' average media sentiment score of 0.19 beat Artivion's score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Artivion 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, AORT or WRBY?

Artivion has higher earnings, but lower revenue than Warby Parker. Artivion is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Artivion $441.33M 2.83 $9.77M $0.24 107.29 Warby Parker $871.91M 3.39 $1.64M $0.02 1,381.20

Is AORT or WRBY more profitable?

Artivion has a net margin of 2.55% compared to Warby Parker's net margin of 0.15%. Artivion's return on equity of 7.15% beat Warby Parker's return on equity. Company Net Margins Return on Equity Return on Assets Artivion 2.55% 7.15% 3.63% Warby Parker 0.15% 2.30% 1.18%

Does the media refer more to AORT or WRBY?

In the previous week, Warby Parker had 2 more articles in the media than Artivion. MarketBeat recorded 3 mentions for Warby Parker and 1 mentions for Artivion. Warby Parker's average media sentiment score of 0.94 beat Artivion's score of 0.00 indicating that Warby Parker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artivion 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Warby Parker 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Artivion (AORT) Competitors

$25.75 +1.44 (+5.92%)

Closing price 07/16/2026 03:59 PM Eastern

Extended Trading

$26.06 +0.32 (+1.22%)

As of 07/16/2026 07:29 PM Eastern

Compare

AORT vs. LIVN, MMED, NVST, IRTC, and WRBY

Should you buy Artivion stock or one of its competitors? MarketBeat compares Artivion with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Artivion include LivaNova (LIVN), MiniMed Group (MMED), Envista (NVST), iRhythm Technologies (IRTC), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry.

How does Artivion compare to LivaNova?

Artivion (NYSE:AORT) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Artivion has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

In the previous week, LivaNova had 2 more articles in the media than Artivion. MarketBeat recorded 3 mentions for LivaNova and 1 mentions for Artivion. LivaNova's average media sentiment score of 1.68 beat Artivion's score of 0.00 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artivion	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LivaNova	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Artivion presently has a consensus price target of $44.17, suggesting a potential upside of 71.52%. LivaNova has a consensus price target of $81.38, suggesting a potential downside of 0.51%. Given Artivion's stronger consensus rating and higher possible upside, equities research analysts clearly believe Artivion is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75
LivaNova	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Artivion has higher earnings, but lower revenue than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artivion	$441.33M	2.83	$9.77M	$0.24	107.29
LivaNova	$1.39B	3.24	-$242.47M	$1.95	41.94

86.4% of Artivion shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 6.3% of Artivion shares are owned by company insiders. Comparatively, 0.4% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

LivaNova has a net margin of 7.48% compared to Artivion's net margin of 2.55%. LivaNova's return on equity of 16.48% beat Artivion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artivion	2.55%	7.15%	3.63%
LivaNova	7.48%	16.48%	7.59%

Summary

LivaNova beats Artivion on 9 of the 16 factors compared between the two stocks.

How does Artivion compare to MiniMed Group?

Artivion (NYSE:AORT) and MiniMed Group (NASDAQ:MMED) are both medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

86.4% of Artivion shares are owned by institutional investors. Comparatively, 19.7% of MiniMed Group shares are owned by institutional investors. 6.3% of Artivion shares are owned by insiders. Comparatively, 2.2% of MiniMed Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Artivion has a net margin of 2.55% compared to MiniMed Group's net margin of 0.00%. Artivion's return on equity of 7.15% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artivion	2.55%	7.15%	3.63%
MiniMed Group	N/A	N/A	N/A

In the previous week, MiniMed Group had 6 more articles in the media than Artivion. MarketBeat recorded 7 mentions for MiniMed Group and 1 mentions for Artivion. MiniMed Group's average media sentiment score of 0.51 beat Artivion's score of 0.00 indicating that MiniMed Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artivion	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Artivion has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artivion	$441.33M	2.83	$9.77M	$0.24	107.29
MiniMed Group	$3.10B	1.44	-$190.97M	-$0.68	N/A

Artivion currently has a consensus target price of $44.17, indicating a potential upside of 71.52%. MiniMed Group has a consensus target price of $21.33, indicating a potential upside of 34.34%. Given Artivion's stronger consensus rating and higher probable upside, equities research analysts clearly believe Artivion is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

Artivion beats MiniMed Group on 11 of the 15 factors compared between the two stocks.

How does Artivion compare to Envista?

Artivion (NYSE:AORT) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Artivion has a net margin of 2.55% compared to Envista's net margin of 2.41%. Artivion's return on equity of 7.15% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artivion	2.55%	7.15%	3.63%
Envista	2.41%	7.11%	3.91%

Artivion has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

Artivion currently has a consensus price target of $44.17, suggesting a potential upside of 71.52%. Envista has a consensus price target of $28.54, suggesting a potential upside of 5.76%. Given Artivion's stronger consensus rating and higher probable upside, analysts plainly believe Artivion is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

86.4% of Artivion shares are held by institutional investors. 6.3% of Artivion shares are held by insiders. Comparatively, 1.0% of Envista shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Envista has higher revenue and earnings than Artivion. Envista is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artivion	$441.33M	2.83	$9.77M	$0.24	107.29
Envista	$2.72B	1.61	$47M	$0.41	65.82

In the previous week, Envista had 3 more articles in the media than Artivion. MarketBeat recorded 4 mentions for Envista and 1 mentions for Artivion. Envista's average media sentiment score of 0.72 beat Artivion's score of 0.00 indicating that Envista is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artivion	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Envista	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Artivion beats Envista on 10 of the 16 factors compared between the two stocks.

How does Artivion compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Artivion (NYSE:AORT) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations.

86.4% of Artivion shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by company insiders. Comparatively, 6.3% of Artivion shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, iRhythm Technologies had 4 more articles in the media than Artivion. MarketBeat recorded 5 mentions for iRhythm Technologies and 1 mentions for Artivion. iRhythm Technologies' average media sentiment score of 0.19 beat Artivion's score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Artivion	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Artivion has lower revenue, but higher earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Artivion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.07	-$44.55M	-$0.86	N/A
Artivion	$441.33M	2.83	$9.77M	$0.24	107.29

iRhythm Technologies currently has a consensus price target of $186.62, suggesting a potential upside of 61.78%. Artivion has a consensus price target of $44.17, suggesting a potential upside of 71.52%. Given Artivion's higher probable upside, analysts clearly believe Artivion is more favorable than iRhythm Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75

Artivion has a net margin of 2.55% compared to iRhythm Technologies' net margin of -3.53%. Artivion's return on equity of 7.15% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Artivion	2.55%	7.15%	3.63%

iRhythm Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Artivion has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

Summary

Artivion beats iRhythm Technologies on 9 of the 17 factors compared between the two stocks.

How does Artivion compare to Warby Parker?

Artivion (NYSE:AORT) and Warby Parker (NYSE:WRBY) are both medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Artivion presently has a consensus target price of $44.17, indicating a potential upside of 71.52%. Warby Parker has a consensus target price of $29.82, indicating a potential upside of 7.94%. Given Artivion's stronger consensus rating and higher probable upside, research analysts clearly believe Artivion is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Artivion	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.75
Warby Parker	0 Sell rating(s)	5 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.67

Artivion has higher earnings, but lower revenue than Warby Parker. Artivion is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Artivion	$441.33M	2.83	$9.77M	$0.24	107.29
Warby Parker	$871.91M	3.39	$1.64M	$0.02	1,381.20

In the previous week, Warby Parker had 2 more articles in the media than Artivion. MarketBeat recorded 3 mentions for Warby Parker and 1 mentions for Artivion. Warby Parker's average media sentiment score of 0.94 beat Artivion's score of 0.00 indicating that Warby Parker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Artivion	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Warby Parker	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

86.4% of Artivion shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 6.3% of Artivion shares are held by company insiders. Comparatively, 16.8% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Artivion has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market. Comparatively, Warby Parker has a beta of 1.91, indicating that its share price is 91% more volatile than the broader market.

Artivion has a net margin of 2.55% compared to Warby Parker's net margin of 0.15%. Artivion's return on equity of 7.15% beat Warby Parker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Artivion	2.55%	7.15%	3.63%
Warby Parker	0.15%	2.30%	1.18%

Summary

Warby Parker beats Artivion on 9 of the 16 factors compared between the two stocks.

Get Artivion News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AORT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AORT vs. The Competition

Export

Metric	Artivion	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$1.18B	$7.56B	$6.96B	$23.43B
Dividend Yield	N/A	1.33%	2.68%	4.19%
P/E Ratio	107.30	50.61	27.21	31.08
Price / Sales	2.83	80.49	519.51	19.92
Price / Cash	22.06	26.61	49.25	33.10
Price / Book	2.72	7.22	10.78	4.78
Net Income	$9.77M	$162.30M	$3.59B	$1.07B
7 Day Performance	6.63%	-1.13%	-2.55%	0.84%
1 Month Performance	20.25%	-0.14%	2.81%	0.92%
1 Year Performance	-18.19%	7.12%	25.42%	18.16%

Artivion Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AORT Artivion	3.702 of 5 stars	$25.75 +5.9%	$44.17 +71.5%	-18.2%	$1.18B	$441.33M	107.30	1,800
LIVN LivaNova	2.17 of 5 stars	$82.98 +0.5%	$80.75 -2.7%	+90.3%	$4.54B	$1.39B	42.55	3,300	Positive News Analyst Forecast
MMED MiniMed Group	2.6311 of 5 stars	$16.10 +5.3%	$21.33 +32.5%	N/A	$4.52B	$3.10B	N/A	8,000	News Coverage
NVST Envista	2.2262 of 5 stars	$26.23 +1.2%	$28.54 +8.8%	+37.0%	$4.22B	$2.72B	63.97	12,000
IRTC iRhythm Technologies	3.9059 of 5 stars	$118.68 +2.2%	$187.38 +57.9%	-15.8%	$3.82B	$747.14M	N/A	2,400	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AORT) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Artivion (AORT) Competitors

AORT vs. LIVN, MMED, NVST, IRTC, and WRBY

How does Artivion compare to LivaNova?

Summary

How does Artivion compare to MiniMed Group?

Summary

How does Artivion compare to Envista?

Summary

How does Artivion compare to iRhythm Technologies?

Summary

How does Artivion compare to Warby Parker?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AORT vs. The Competition

Artivion Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Artivion (AORT) Competitors

AORT vs. LIVN, MMED, NVST, IRTC, and WRBY

How does Artivion compare to LivaNova?

Which has more volatility and risk, AORT or LIVN?

Does the media favor AORT or LIVN?

Do analysts recommend AORT or LIVN?

Which has better valuation & earnings, AORT or LIVN?

Do insiders and institutionals hold more shares of AORT or LIVN?

Is AORT or LIVN more profitable?

Summary

How does Artivion compare to MiniMed Group?

Do institutionals and insiders have more ownership in AORT or MMED?

Is AORT or MMED more profitable?

Does the media favor AORT or MMED?

Which has better valuation and earnings, AORT or MMED?

Do analysts recommend AORT or MMED?

Summary

How does Artivion compare to Envista?

Is AORT or NVST more profitable?

Which has more volatility & risk, AORT or NVST?

Do analysts rate AORT or NVST?

Do insiders and institutionals hold more shares of AORT or NVST?

Which has preferable valuation and earnings, AORT or NVST?

Does the media favor AORT or NVST?

Summary

How does Artivion compare to iRhythm Technologies?

Do institutionals and insiders hold more shares of IRTC or AORT?

Does the media refer more to IRTC or AORT?

Which has higher valuation and earnings, IRTC or AORT?

Do analysts prefer IRTC or AORT?

Is IRTC or AORT more profitable?

Which has more risk and volatility, IRTC or AORT?

Summary

How does Artivion compare to Warby Parker?

Do analysts prefer AORT or WRBY?

Which has stronger valuation and earnings, AORT or WRBY?

Does the media refer more to AORT or WRBY?

Do insiders & institutionals have more ownership in AORT or WRBY?

Which has more risk & volatility, AORT or WRBY?

Is AORT or WRBY more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AORT vs. The Competition

Artivion Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools